Expertise in
1
conditions

Lourdes F. Calvo

A Coruna, GA, ES 
Expertise in
1
conditions
A Coruna, GA, ES 

Overview

Lourdes Calvo practices practicing medicine in A Coruna, Spain.

Ms. Calvo is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Menopause, and Inflammatory Breast Cancer.

She is actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

A Coruna, GA, Spain
Other Locations
Leon, CL 24071, Spain
Madrid, MD 28040, Spain
A Coruňa
Complejo Hospitalario Universitario De A Coruňa, Spain
Onkologikoa
San Sebastian, PV, Spain
Complejo Hospitalario Universitario Santiago de Compostela
Santiago De Compostela, GA, Spain
Barcelona, CT, Spain
Coruna Del Conde, CL 15006, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Chemotherapy-Free pCR-Guided Strategy With Subcutaneous Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer (PHERGAIN-2)
Chemotherapy-Free pCR-Guided Strategy With Subcutaneous Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer (PHERGAIN-2)
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2026
Intervention Type: Drug
Study Drugs: Trastuzumab, Pertuzumab
Study Phase: Phase 2
A Two-stage Simon Design Phase II Study for NOn-BRCA Metastatic BReast Cancer (MBC) Patients With Homologous Recombination Deficiency Treated With OLAparib Single Agent
A Two-stage Simon Design Phase II Study for NOn-BRCA Metastatic BReast Cancer (MBC) Patients With Homologous Recombination Deficiency Treated With OLAparib Single Agent
Enrollment Status: Terminated
Publish Date: February 22, 2023
Intervention Type: Drug
Study Drug: Olaparib
Study Phase: Phase 2
An International, Non-controlled Phase II Trial to Identify the Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge Upon Progression to a Palbociclib Combination in ER-positive Metastatic Breast Cancer Patients
An International, Non-controlled Phase II Trial to Identify the Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge Upon Progression to a Palbociclib Combination in ER-positive Metastatic Breast Cancer Patients
Enrollment Status: Completed
Publish Date: June 21, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

63 Total Publications

Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 25, 2025

Frequently Asked Questions about Lourdes F. Calvo

Is Lourdes F. Calvo a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Lourdes F. Calvo is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lourdes F. Calvo participate in research or clinical trials?

Yes. Lourdes F. Calvo has published 63 articles and abstracts on conditions like Breast Cancer. You can view a list of Lourdes F. Calvo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Calvo's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile